Bookmark and Share

Major Movers on December 12; AET, SCMP, YMI, DLB, GEOS, DD, BGMD, ALNY, MCP, LLY

Shares of health insurer, Aetna Inc. (NYSE: AET) gained 4 percent after the company boosted its outlook both on revenue and earnings for the next fiscal year.

Shares Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP) gained around 5.5 percent on Wednesday after the company announced that Food and Drug Administration (FDA) has approved its   supplemental new drug application for its glaucoma treatment.

YM BioSciences Inc. (USA) (NYSEAMEX:YMI) shares skyrocketed on Wednesday, gaining nearly 80 percent after both Gilead Sciences Inc and YM BioSciences Inc announced that the companies have signed a definitive agreement which would allow Gilead to acquire YM for US$2.95 per share in cash.

Board of Directors from both companies approved the transaction unanimously. The transaction values YM at about US$10 million, with YM’s balance sheet showing CAD125.5 million in cash and cash equivalents as of September 30, 2012. Gilead intends to fiancé the acquisition with cash on hand. The transaction is likely to close in the first quarter of 2013.

Shares Dolby Laboratories Inc. (NYSE:DLB) climbed 6 percent after the company following closing bell on Tuesday announced that Board of Directors approved onetime special dividend of $ 4 a share both for its A class and B class common stockholders.

Geospace Technologies Corp. (NASDAQ:GEOS) shares fell 6 percent after seismic equipment manufacturer reported 19 percent jump in fiscal fourth quarter profits; nevertheless, it missed analysts’ expectation.

Dupont Co (NYSE: DD) shares edged up on Wednesday after global diversified chemical manufacturer announced that it will be repurchasing shares worth $ 1 billion, as it looks to enhance the shareholder value.

Shares of BG Medicine Inc. (NASDAQ:BGMD) rallied nearly 13.5 percent after the company announced that it obtained a CE Mark, which would allow the commercial sale of the CardioSCORE test in the EU and other countries that recognize the CE Mark.

The CardioSCORE test is a patented diagnostic blood test. CardioSCORE significantly improves risk prediction of major cardiovascular complications, a feature which is not available in traditional risks factors assessments for instance Framingham Risk Score and European SCORE.

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) shares jumped 6 percent after research analysts at Piper Jaffray boosted Stock’s rating from “neutral” to “overweight”. The equity research firm lifted its target price on the stock to $25 from $19. Earlier in November, the Company had reported lighter-than-expected fiscal third quarter loss; nevertheless revenue missed analysts’ consensual estimate.

Molycorp Inc (NYSE:MCP) shares slipped on Wednesday after the board of rare metal company ousted its President and Chief executive Mark Smith. Mr. Smith was at the helm of affairs for more than five years.  During his tenure the company went public. Meanwhile, the board has appointed director Constantine Karayannopoulos as interim CEO until a permanent replacement is found.

Shares Eli Lilly & Co. (NYSE:LLY) lost over 3 percent after the drug giant said that it will not apply for a license for its  Alzheimer’s treatment until it conduct its  second Phase- 3 study. The Company expects to commence its second phase-3 study no later than the third quarter of next year.

Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

All stories in are for informational purposes only. This is NOT a stock recommendation. This story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at . About is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.